Postmenopausal steroid replacement with micronized dehydroepiandrosterone: Preliminary oral bioavailability and dose proportionality studies
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 166 (4) , 1163-1170
- https://doi.org/10.1016/s0002-9378(11)90602-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cellsEuropean Journal of Immunology, 1990
- ANTIGLUCOCORTICOID ACTIONS OF DEHYDROEPIANDROSTERONE AND LOW CONCENTRATIONS IN ALZHEIMER'S DISEASEThe Lancet, 1989
- Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA)Journal of Medical Virology, 1988
- A Prospective Study of Dehydroepiandrosterone Sulfate, Mortality, and Cardiovascular DiseaseNew England Journal of Medicine, 1986
- The influence of subsequent dehydroepiandrosterone, diaminopropane, phenobarbital, butylated hydroxyanisole and butylated hydroxytoluene treatment on the development of preneoplastic and neoplastic lesions in the rat initiated with di-hydroxy-di-N-propyl nitrosamineCancer Letters, 1986
- Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone.Journal of Clinical Investigation, 1985
- Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic miceDiabetes, 1982
- The Fetal Adrenal GlandAnnual Review of Physiology, 1981
- Decreased adrenal androgen sensitivity to ACTH during agingMetabolism, 1981
- Increasing oral bioavailability of progesterone by formulationThe Journal of Steroid Biochemistry and Molecular Biology, 1978